INVESTOR NEWS no. 57 - 8 August 2024 DFDS expects to publish the report for Q2 2024 on 14 August 2024 at around 07:30 CET. Torben Carlsen, CEO, and Karen Boesen, CFO, will present the report on a live conference call. The presentation will be followed by …
The contract will help replenish inventory of bulk vaccine required for future manufacturing and supply of freeze-dried vaccines. COPENHAGEN, Denmark, August 8, 2024 – Bavarian Nordic A/S (OMX: BAVA) today announced that it has received a new order …
Kontrakten understøtter produktion af ny råvaccine til delvis genopfyldning af lageret til fremtidig produktion og levering af frysetørrede vacciner KØBENHAVN, Danmark, 8. august 2024 – Bavarian Nordic A/S (OMX: BAVA) meddelte i dag, at selskabet har …
Annual conference takes place in Arlington, Virginia on October 30 WASHINGTON, D.C., UNITED STATES, August 7, 2024 /EINPresswire.com/ -- Newsmatics, has committed to being a gold level and media sponsor of the Mid-Atlantic Marcom Summit, which will take …
Nice to see Konstant making news again. This time it’s about their latest itemization in Enterprise App Development Companies in New York City! UNITED STATES, August 7, 2024 /EINPresswire.com/ -- New York City or the Big Apple is a global center to the …
Chooses Execute AFE to Eliminate Bottlenecks Spurred by Legacy System HOUSTON, TEXAS, UNITED STATES OF AMERICA, August 6, 2024 /EINPresswire.com/ -- Quorum Software (Quorum), a global software leader dedicated to the energy industry, today …
Company Announcement Genmab to assume sole responsibility for the continued development and potential commercialization of acasunlimab BioNTech has opted not to participate in the further development of the acasunlimab program under the parties’ existing …
AesirX unveils limited Partnership Packages for WordPress agencies - exclusive benefits for early adopters committed to open source privacy and GDPR compliance NEW YORK, USA, August 1, 2024 /EINPresswire.com/ -- AesirX is committed to open source …
Nilfisk boosts its financial reserves with a €225M Schuldschein loan, arranged by UniCredit, Danske Bank, Nordea, and BNP Paribas as joint arrangers. COPENHAGEN, DENMARK, July 31, 2024 /EINPresswire.com/ -- The placed volume is allocated to …
July 30, 2024 News Release BioPorto Announces NIH-Funded Study to Explore the Ability of Renal Biomarkers in Predicting Severe AKI, Advancing Beyond NLP-based AI Algorithms ADLM 2024 Conference – Chicago, July 30, 2024 – BioPorto Diagnostics, a pioneering …
Press release – 7 / 2024 Zealand Pharma Appoints Eric Cox as Chief Commercial Officer Copenhagen, Denmark, 29 July 2024 – Zealand Pharma A/S (Nasdaq Copenhagen: ZEAL) (CVR-no. 20045078), a biotechnology company focused on the discovery and development of …
July 29, 2024 News Release BioPorto to Debut FDA Approved ProNephro AKI at Upcoming ADLM 2024 Clinical Lab Expo ADLM 2024 Conference – Chicago, July 29, 2024 – BioPorto Diagnostics, a company specializing in in vitro diagnostics with an emphasis on the …
Trademark Lawyer Hancel Wendy Diaz discusses Innovations in Trademark Protection: Latest in Technology & Legislation, highlighting advancements and updates SANTO DOMINGO, DISTRITO NACIONAL, REPúBLICA DOMINICANA, July 27, 2024 /EINPresswire.com/ -- …
INVESTOR NEWS nr. 54 - 26. juli 2024 DFDS vil forlade space charteraftalen med P&O Ferries, der omfatter Dover-Calais-ruten, med virkning fra slutningen af august 2024. Space charteraftalen blev indgået i maj 2021 for at styrke færgeproduktet til …
INVESTOR NEWS no. 54 - 26 July 2024 DFDS will leave the space charter agreement with P&O Ferries covering the Dover-Calais route effective from end August 2024. The space charter agreement was entered into in May 2021 to enhance the ferry offering to …
Boston (July 26, 2024)—Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated to developing personalized cancer treatments, announced that its Board of Directors has decided to …
Boston (July 24, 2024)—Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated to developing personalized cancer treatments, encourages its stockholders to participate actively in …
BRENTWOOD, TN, UNITED STATES, July 23, 2024 /EINPresswire.com/ -- Currax Pharmaceuticals LLC (“Currax”) today announced the approval of additional manufacturing site for CONTRAVE®/MYSIMBA® in the European Union (EU) and European Union …
Celebrating half a century of innovation and dedication to the energy industry HOUSTON, TEXAS, UNITED STATES, July 23, 2024 /EINPresswire.com/ -- Coastal Flow Measurement, a key solution within the Quorum Energy Suite and a leader in North American …
Innovative AI-Powered Smoking Cessation App Nico Earns Prestigious Iron A' Design Award Recognition COMO, CO, ITALY, July 22, 2024 /EINPresswire.com/ -- The A' Design Award and Competition, a highly respected award in the field of mobile design …
07 days 03:22:16
